RPL10 and cancer: For instance, the T-ALL-associated RPL10-R98S mutation protects leukemia cell survival via specific upregulation of IRES-dependent translation of the antiapoptotic molecule BCL2.198 Studies of cancer susceptibility in ribosomopathies also provide the evidence for oncogenic transformation through translation reprogramming.